1. Home
  2. BLTE vs PRGO Comparison

BLTE vs PRGO Comparison

Compare BLTE & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • PRGO
  • Stock Information
  • Founded
  • BLTE 2018
  • PRGO 1887
  • Country
  • BLTE United States
  • PRGO Ireland
  • Employees
  • BLTE N/A
  • PRGO N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • PRGO Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLTE Health Care
  • PRGO Health Care
  • Exchange
  • BLTE Nasdaq
  • PRGO Nasdaq
  • Market Cap
  • BLTE 2.6B
  • PRGO 3.1B
  • IPO Year
  • BLTE 2022
  • PRGO 1991
  • Fundamental
  • Price
  • BLTE $93.82
  • PRGO $21.94
  • Analyst Decision
  • BLTE Strong Buy
  • PRGO Buy
  • Analyst Count
  • BLTE 4
  • PRGO 3
  • Target Price
  • BLTE $96.00
  • PRGO $34.00
  • AVG Volume (30 Days)
  • BLTE 69.4K
  • PRGO 1.6M
  • Earning Date
  • BLTE 11-11-2025
  • PRGO 11-05-2025
  • Dividend Yield
  • BLTE N/A
  • PRGO 5.41%
  • EPS Growth
  • BLTE N/A
  • PRGO N/A
  • EPS
  • BLTE N/A
  • PRGO N/A
  • Revenue
  • BLTE N/A
  • PRGO $4,326,100,000.00
  • Revenue This Year
  • BLTE N/A
  • PRGO $2.23
  • Revenue Next Year
  • BLTE N/A
  • PRGO $0.54
  • P/E Ratio
  • BLTE N/A
  • PRGO N/A
  • Revenue Growth
  • BLTE N/A
  • PRGO N/A
  • 52 Week Low
  • BLTE $49.00
  • PRGO $20.52
  • 52 Week High
  • BLTE $93.59
  • PRGO $30.93
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 77.42
  • PRGO 50.68
  • Support Level
  • BLTE $88.00
  • PRGO $21.30
  • Resistance Level
  • BLTE $91.92
  • PRGO $22.02
  • Average True Range (ATR)
  • BLTE 3.16
  • PRGO 0.54
  • MACD
  • BLTE 0.90
  • PRGO 0.09
  • Stochastic Oscillator
  • BLTE 98.97
  • PRGO 93.73

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Share on Social Networks: